Wegovy Result UK - Cheapest Price £69.00 | Real Outcomes

Clinically Proven UK Registered Pharmacy

Wegovy Result - Cheapest UK Price From £69.00

Get Wegovy at the cheapest UK price from £69.00 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£89.00 From £69.00 £20 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding Wegovy Result Expectations: What Clinical Evidence Shows

When evaluating wegovy result data, it's essential to understand what clinical trials demonstrate and what realistic outcomes you can expect. As a UK-registered pharmacy with thousands of patients supported through their weight loss journey, we've seen firsthand how Wegovy (semaglutide) performs in real-world settings. The STEP clinical trial programme provides robust evidence on efficacy, timelines, and the factors that influence individual outcomes.

What Wegovy Result Data Shows from Clinical Trials

The wegovy result evidence base comes primarily from the STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme, which enrolled over 4,500 participants across multiple studies [1]. In the landmark STEP 1 trial, participants achieved an average weight loss of 14.9% of their initial body weight over 68 weeks, compared to 2.4% with placebo [1]. This represents approximately 15kg for someone starting at 100kg, though individual results varied significantly.

What makes the wegovy result profile particularly compelling is the consistency across different populations. STEP 2 studied people with type 2 diabetes and showed average weight loss of 9.6% over 68 weeks [2]. STEP 3 combined Wegovy with intensive behavioural therapy and achieved 16.0% average weight loss [2]. These trials demonstrate that semaglutide works across diverse patient groups, though outcomes improve when combined with lifestyle modification.

It's crucial to understand that clinical trial conditions differ from real-world use. Trial participants received regular support, dietary counselling, and close monitoring. At Cured Pharmacy, we provide comprehensive guidance to help replicate these supportive conditions, but individual wegovy result outcomes will depend on adherence, lifestyle changes, and metabolic factors unique to each person.

Timeline of Wegovy Result Progression: What to Expect Each Month

Understanding the wegovy result timeline helps set realistic expectations. Weight loss with Wegovy follows a dose-escalation schedule over 16-20 weeks, with results typically becoming noticeable after 4-8 weeks [3]. During the initial 0.25mg dose (weeks 1-4), most patients lose 1-2% of body weight as the medication begins to reduce appetite and slow gastric emptying.

The most significant wegovy result acceleration occurs between weeks 12-32, when patients reach therapeutic doses of 1.7mg and 2.4mg. During this period, average monthly weight loss ranges from 2-4% of initial body weight, though this varies considerably [3]. Peak weight loss typically occurs around week 60-68, after which most patients enter a maintenance phase where weight stabilises.

It's important to note that wegovy result patterns are not linear. Some weeks show minimal change, followed by more substantial losses. Plateaus are normal and don't indicate treatment failure. Our clinical team at Cured Pharmacy monitors progress and adjusts support strategies to help patients navigate these natural fluctuations while maintaining motivation throughout their treatment journey.

Factors That Influence Individual Wegovy Result Outcomes

Individual wegovy result variation stems from multiple factors including baseline BMI, metabolic health, adherence to dosing schedules, dietary quality, physical activity levels, sleep patterns, and genetic factors affecting GLP-1 receptor sensitivity [4]. Patients with higher starting BMI often lose more absolute weight but similar percentages. Those who combine Wegovy with structured nutrition plans and regular physical activity consistently achieve superior outcomes compared to medication alone.

Age and hormonal status also affect results. Perimenopausal and postmenopausal women may experience slower initial weight loss due to metabolic changes, though final outcomes remain comparable with sustained treatment [4]. Men typically lose weight slightly faster in the first 12 weeks but outcomes equalise by month 6. Previous dieting history, particularly yo-yo dieting, can temporarily slow initial response as the body adapts to consistent energy deficit.

Comparing Wegovy Result Data to Other Weight Loss Treatments

When evaluating wegovy result performance against alternatives, head-to-head trials provide the clearest picture. Compared to liraglutide (Saxenda), semaglutide demonstrates superior efficacy: the STEP 8 trial showed 15.8% weight loss with Wegovy versus 6.4% with Saxenda over 68 weeks [5]. This nearly 2.5-fold difference makes Wegovy the most effective GLP-1 medication currently licensed for weight management in the UK.

Against tirzepatide (Mounjaro), which combines GLP-1 and GIP receptor agonism, the wegovy result profile shows slightly lower average weight loss. The SURMOUNT-1 trial demonstrated 20.9% average weight loss with tirzepatide 15mg versus approximately 15% with semaglutide in comparative analyses [5]. However, Wegovy remains highly effective, and some patients tolerate it better than dual-agonist therapies.

Compared to orlistat, the only non-injectable weight loss medication widely available in the UK, wegovy result data shows substantially greater efficacy. Orlistat typically produces 3-5% weight loss, approximately one-third of Wegovy's effect [6]. While orlistat works through fat malabsorption rather than appetite regulation, the difference in magnitude makes GLP-1 agonists the preferred option for patients seeking clinically significant weight reduction, subject to prescriber assessment.

Treatment Average Weight Loss Injection Frequency Starting Price
Wegovy (Semaglutide) 14.9% over 68 weeks Once weekly from £89.00
Mounjaro (Tirzepatide) 20.9% over 72 weeks Once weekly from £145.00
Saxenda (Liraglutide) 6.4% over 68 weeks Daily from £68.00
Orlistat 3-5% over 12 months Three times daily (oral) from £32.00
Xenical (Orlistat) 3-5% over 12 months Three times daily (oral) from £49.99

Maximising Your Wegovy Result: Evidence-Based Strategies

To optimise your wegovy result outcome, clinical evidence supports several key strategies. Protein intake of 1.2-1.6g per kilogram of ideal body weight helps preserve lean muscle mass during weight loss, which maintains metabolic rate and improves long-term sustainability [7]. Resistance training 2-3 times weekly further protects muscle tissue and enhances body composition changes beyond what scale weight alone reveals.

Hydration significantly impacts wegovy result perception and actual efficacy. Adequate water intake (2-3 litres daily) helps manage the medication's effect on gastric emptying, reduces constipation risk, and supports the body's metabolic processes during energy deficit. Many patients report better tolerance and more consistent weight loss when maintaining proper hydration throughout treatment.

Sleep quality directly correlates with wegovy result outcomes. Studies show that patients sleeping 7-9 hours nightly lose 25-30% more weight than those with disrupted sleep, likely due to effects on hunger hormones ghrelin and leptin [7]. At Cured Pharmacy, we provide comprehensive lifestyle guidance alongside medication supply to help patients implement these evidence-based strategies and achieve optimal results within their individual capacity.

Monitoring Progress Beyond Scale Weight

While scale weight provides one measure of wegovy result success, comprehensive monitoring includes waist circumference, body composition analysis, energy levels, mobility improvements, and cardiometabolic markers like blood pressure and HbA1c [8]. Many patients experience significant health improvements before substantial weight loss appears, particularly in blood sugar control and blood pressure reduction. These early wins provide motivation during periods of slower scale movement.

Photographic documentation every 4 weeks captures visual changes that daily mirror checks miss. Clothing fit often changes before weight drops significantly, as body composition shifts toward less visceral fat and more muscle density. Our clinical team recommends tracking multiple metrics to maintain perspective and recognise the full spectrum of health improvements Wegovy facilitates beyond the number on the scale.

Long-Term Wegovy Result Sustainability and Maintenance

The wegovy result sustainability question is critical for patients considering long-term treatment. The STEP 4 trial specifically addressed this by randomising patients who achieved weight loss on Wegovy to either continue treatment or switch to placebo [2]. Those continuing Wegovy maintained their weight loss and lost an additional 7.9% over 48 weeks, while those switched to placebo regained 6.9% of their body weight [2].

This data demonstrates that Wegovy works as a chronic disease medication rather than a short-term intervention. Obesity is a chronic metabolic condition, and the wegovy result maintenance requires ongoing treatment in most cases. However, some patients successfully transition to lower maintenance doses after reaching their goal weight, reducing both cost and injection frequency while preserving most of their weight loss.

At Cured Pharmacy, we support patients through both active weight loss and maintenance phases. Our pricing from £69.00 makes long-term treatment more accessible, and our clinical team works with patients to find the minimum effective maintenance dose. This individualised approach balances ongoing wegovy result preservation with practical considerations around cost, convenience, and each patient's evolving health goals, always subject to prescriber approval.

Accessing Wegovy Result Outcomes at the Cheapest UK Price

Achieving your wegovy result goals shouldn't be limited by excessive cost. At Cured Pharmacy, we offer Wegovy at the cheapest UK price from £69.00, with an additional £20 off your first order using code Weightlossnew. This transparent pricing is shown upfront, before your clinical consultation, so you can make informed decisions about your weight loss investment without hidden fees or surprise charges.

Our service combines competitive pricing with comprehensive clinical support. Every patient completes a thorough online assessment reviewed by our UK-registered prescribers, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073). This ensures Wegovy is clinically appropriate for your individual circumstances and that you understand how to use it safely to maximise your wegovy result potential.

We provide next-day delivery in discreet packaging, ongoing clinical support throughout your treatment, and access to our pharmacy team for questions about dosing, side effects, or optimising your results. All medications are genuine UK-licensed products sourced through regulated channels. Starting your wegovy result journey with Cured Pharmacy means accessing expert care at the lowest guaranteed UK price, with the clinical oversight necessary for safe, effective weight loss treatment.

Why Choose Cured Pharmacy for Your Wegovy Treatment

Cured Pharmacy is a fully registered UK pharmacy (GPhC 9012511) committed to making effective weight loss treatment accessible and affordable. Our transparent pricing model, expert clinical team, and patient-focused service have supported thousands of individuals in achieving meaningful wegovy result outcomes. We never compromise on clinical safety or medication quality, sourcing only genuine UK-licensed Wegovy directly from authorised suppliers.

Our online consultation takes under 3 minutes and provides same-day prescriber review in most cases. We understand that starting weight loss treatment is a significant decision, which is why we offer clear information, honest pricing, and ongoing support throughout your journey. Contact our team on (+44) 116 4646009 with any questions, or start your assessment today to begin experiencing the wegovy result benefits that clinical trials have demonstrated.

Scientific References

  1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.
  2. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984.
  3. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425.
  4. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091.
  5. Rubino, D. M., Greenway, F. L., Khalid, U., O'Neil, P. M., Rosenstock, J., Sørrig, R., ... & Investigators, S. (2022). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA, 327(2), 138-150.
  6. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management. Clinical guideline [CG189]. NICE.
  7. Lundgren, J. R., Janus, C., Jensen, S. B., Juhl, C. R., Olsen, L. M., Christensen, R. M., ... & Torekov, S. S. (2021). Healthy weight loss maintenance with exercise, liraglutide, or both combined. New England Journal of Medicine, 384(18), 1719-1730.
  8. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How quickly will I see wegovy result changes on the scale?
Most patients notice initial wegovy result changes within 4-8 weeks of starting treatment, with more significant weight loss occurring between weeks 12-32 as doses increase to therapeutic levels. Individual timelines vary based on adherence, lifestyle factors, and metabolic response.
What is the average wegovy result in clinical trials?
Clinical trials showed an average wegovy result of 14.9% total body weight loss over 68 weeks in the STEP 1 trial, representing approximately 15kg for someone starting at 100kg. Individual results ranged from minimal response to over 20% weight loss.
Can I achieve better wegovy result outcomes with diet and exercise?
Yes, combining Wegovy with structured nutrition and regular physical activity consistently produces superior wegovy result outcomes. The STEP 3 trial combining medication with intensive behavioural therapy achieved 16.0% average weight loss compared to 14.9% with medication and standard support.
Will my wegovy result continue after reaching my goal weight?
Wegovy result maintenance requires ongoing treatment in most cases. The STEP 4 trial showed patients continuing Wegovy maintained their weight loss and lost additional weight, while those stopping regained an average of 6.9% body weight over 48 weeks.
How does wegovy result compare to Mounjaro for weight loss?
Wegovy produces an average 14.9% weight loss while Mounjaro (tirzepatide) achieves approximately 20.9% in clinical trials. Both are highly effective, though wegovy result outcomes remain clinically significant and some patients tolerate semaglutide better than dual-agonist therapies.
What factors affect my individual wegovy result?
Individual wegovy result variation depends on baseline BMI, adherence to dosing, dietary quality, physical activity, sleep patterns, metabolic health, hormonal status, and genetic factors affecting GLP-1 receptor sensitivity. Combining medication with lifestyle changes optimises outcomes.
Is the wegovy result permanent or will I regain weight after stopping?
Clinical evidence shows most patients regain weight after discontinuing Wegovy, as obesity is a chronic metabolic condition requiring ongoing management. However, lifestyle changes maintained during treatment can help preserve some wegovy result benefits, and some patients successfully transition to lower maintenance doses.
Where can I get Wegovy at the cheapest UK price to start seeing results?
Cured Pharmacy offers Wegovy at the cheapest UK price from £69.00, with £20 off your first order using code Weightlossnew. All treatments require clinical assessment by our UK-registered prescribers to ensure safety and appropriateness for your individual circumstances.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 30 July 2026